Rising incidence and clinical impact of kidney cancer in China and worldwide: a call for targeted prevention, early diagnosis, and equitable treatment

Over 30 years, kidney cancer burden has risen sharply with regional, demographic, and gender disparities. China needs to reduce urban-rural gaps and improve early diagnosis. Globally, limited care access persists in low-income areas. Rising high BMI calls for metabolic interventions. Public health must ensure equitable care and targeted prevention to combat this burden.